We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$571M
AUM Growth
+$64.7M
Cap. Flow
+$77M
Cap. Flow %
13.5%
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$35.4M
2
STLA icon
Stellantis
STLA
+$22.2M
3
PEP icon
PepsiCo
PEP
+$18M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$6.64M
5
KSS icon
Kohl's
KSS
+$5.18M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$21.5M
2
EIDO icon
iShares MSCI Indonesia ETF
EIDO
+$11.1M
3
ETN icon
Eaton
ETN
+$4.76M
4
DAL icon
Delta Air Lines
DAL
+$4.4M
5
WU icon
Western Union
WU
+$4.14M

Sector Composition

Rank Sector Weight
1 Financials 13.66%
2 Consumer Discretionary 12.98%
3 Consumer Staples 8.41%
4 Energy 8.01%
5 Industrials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UG icon
426
United-Guardian
UG
$33.2M
$20.7K ﹤0.01%
1,100
-300
-21% -$5.78K
AAL icon
427
American Airlines Group
AAL
$10.2B
$17.9K ﹤0.01%
550
-7,513
-93% -$243K
LTHM
428
DELISTED
Livent Corporation
LTHM
$17.9K ﹤0.01%
2,590
CC icon
429
Chemours
CC
$2.57B
$17.7K ﹤0.01%
736
+626
+569% +$18.4K
MDLZ icon
430
Mondelez International
MDLZ
$80.5B
$17.6K ﹤0.01%
326
+33
+11% +$1.71K
BMA icon
431
Banco Macro
BMA
$6.02B
$17K ﹤0.01%
234
-2,367
-91% -$122K
INCY icon
432
Incyte
INCY
$24.9B
$16.9K ﹤0.01%
+199
New +$16K
ENOV icon
433
Enovis
ENOV
$1.69B
$16.3K ﹤0.01%
338
ULTA icon
434
Ulta Beauty
ULTA
$22.2B
$16K ﹤0.01%
46
+34
+283% +$11.8K
FTI icon
435
CALL
TechnipFMC
FTI
$27.5B
$15.1K ﹤0.01%
87
-875
-91% -$15.3K
TS icon
436
Tenaris
TS
$28.6B
$14.9K ﹤0.01%
566
+235
+71% +$6.28K
VRN
437
DELISTED
Veren
VRN
$14.8K ﹤0.01%
4,482
TTD icon
438
Trade Desk
TTD
$8.59B
$14.3K ﹤0.01%
630
-730
-54% -$15.7K
MELI icon
439
Mercado Libre
MELI
$95.6B
$14.1K ﹤0.01%
+23
New +$12.8K
LULU icon
440
lululemon athletica
LULU
$13.6B
$13.9K ﹤0.01%
77
-491
-86% -$85.3K
YPF icon
441
YPF
YPF
$20.4B
$13.7K ﹤0.01%
754
-2,725
-78% -$41.9K
NVR icon
442
NVR
NVR
$16.8B
$13.5K ﹤0.01%
4
+3
+300% +$9.62K
MNST icon
443
Monster Beverage
MNST
$95.5B
$12.7K ﹤0.01%
398
-5,308
-93% -$160K
KMX icon
444
CarMax
KMX
$8.33B
$12.7K ﹤0.01%
+146
New +$11.4K
CMG icon
445
Chipotle Mexican Grill
CMG
$49.4B
$12.5K ﹤0.01%
+850
New +$12K
GSV
446
DELISTED
Gold Standard Ventures Corp.
GSV
$12.4K ﹤0.01%
11,893
HAS icon
447
Hasbro
HAS
$13.4B
$11.4K ﹤0.01%
108
+107
+10,700% +$10.5K
MAA icon
448
Mid-America Apartment Communities
MAA
$15.5B
$11.1K ﹤0.01%
94
+93
+9,300% +$10.5K
PSA icon
449
Public Storage
PSA
$59.3B
$11K ﹤0.01%
46
+36
+360% +$8.26K
CCI icon
450
Crown Castle
CCI
$33.4B
$10.8K ﹤0.01%
83
-1,232
-94% -$158K

Similar funds

Exane Derivatives's Q2 2019 Portfolio in Review

As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.

  • Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
  • Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
  • Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
  • Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
  • Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
  • Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
  • Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.